YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 11, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower an…
PharmaCielo is actively working with more than 24 customers in 15 countries globally, with a focus on psychoactive APIs and dried flower. The Company recently made its first shipment of THC Distillate and THC-Dominant Dried Flower to a cus…
The Company has products in various stages of testing and sales with more than 40 customers in 11 countries, with continued growth expected for the year. Q1 2023 revenue of $786,498; Adjusted EBITDA loss of $1.9 million. PharmaCielo contin…
Represents PharmaCielo's first shipment to South Africa, which has well-established export networks in the UK and Australia, and other potential markets, globally. Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - May 16, 2023) -…
During 2022, PharmaCielo made shipments to 23 clients in 9 countries, with continued growth expected for 2023. The Company's measured investments in revenue-generating sales channels resulted in revenues of $5.3 million in 2022, almost thr…
Will bring unique high-THC Colombian strains owned by PharmaCielo to Europe for the first time. Combines PharmaCielo's expertise in producing premium medicinal cannabis products, with CANNPRISMA's conversion capabilities, to bring patients…
VANCOUVER, BC, April 14, 2023 /CNW/ - TSX VENTURE COMPANIES BULLETIN TYPE: Cease Trade Order BULLETIN DATE: April 14, 2023 TSX Venture Company A Cease Trade Order has been issued by the by the Ontario and Quebec Securities Commissions on A…
PharmaCielo has received a purchase order for CBD Isolate as an API, which will be used by a large pharmaceutical company in Brazil (the "Customer"), for final testing. The Customer has already qualified PharmaCielo as a supplier of API –…
Steady progress against the efficiency plans initiated in mid-2021 with the transition to the current senior management team. Expects a reduction in its annualized fixed costs by approximately 25% compared to 2022 as a result of these ongo…
Ease Labs Pharma, a global pharmaceutical company headquartered in Brazil, has received regulatory approval from the Brazilian Health Regulatory Agency (ANVISA) to launch its Canabidiol Ease Labs 100 mg/ml in Brazil beginning in January 20…
Represents PharmaCielo's first shipment to Africa. Morocco is pioneering the commercialization of cannabinoid products on the African continent and will be a growing market. The Company also announced that it has agreed to issue shares in…
TORONTO and RIONEGRO, Colombia, Nov. 22, 2022 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of dried cannabis flower and medicinal-gr…
VANCOUVER, BC, Nov. 21, 2022 /CNW/ - The following issues have been halted by IIROC: Company: Pharmacielo Ltd. TSX-Venture Symbol: PCLO.WT All Issues: No Reason: Pending Delisting Halt Time (ET): 12:00 PM IIROC can make a decision to impos…
In the first nine months of 2022, PharmaCielo has made shipments to 23 customers in nine countries, with continued growth expected for 2023. The Company has more than doubled Revenue to $3.8 million in the first nine months of 2022, compar…
This is PharmaCielo's second pharmaceutical grade product shipment to a well-established Latin American pharmaceutical company with operations in Uruguay. TORONTO and RIONEGRO, Colombia, Oct. 12, 2022 /CNW/ - PharmaCielo Ltd. ("PharmaCielo…
Shipment made to an established pharmaceutical distributor and clinical research organization in the Czech Republic, focused on medicinal grade cannabinoids TORONTO and RIONEGRO, Colombia, Sept. 15, 2022 /CNW/ - PharmaCielo Ltd. ("PharmaCi…
Colombian government has maintained its commitment to supporting its cannabis producers and building a dominant global export industry. Five tonne quota to grow THC-dominant cannabis strains for export as dried flower will support the fulf…
The Company continues to grow sales and expects to build momentum through the remainder of 2022 and through 2023, with recent progress in Israel, Brazil and Mexico. PharmaCielo product has been sold in 14 countries to date, and the Company…
The Company expects to begin exporting dried flower to Israel in early 2023. Israel is one of the largest importers of medical cannabis in the world, with 109,352 active medical patients in 2021 (+35% vs. 2020)1. TORONTO and RIONEGRO, Colo…
This month, we saw the PharmaCielo Ltd. (CVE:PCLO) up an impressive 42%. But only the myopic could ignore the astounding decline over three years. Indeed, the share price is down a whopping 89% in the last three years. So we're relieved fo…
The Company has made a pre-commercial shipment of CBD isolate to its Mexican joint venture, to support product development by a Mexican phytotherapeutic company. TORONTO and RIONEGRO, Colombia , Aug. 4, 2022 /CNW/ - PharmaCielo Ltd. ("Phar…
TORONTO and RIONEGRO, Colombia , July 28, 2022 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade can…
The Company has shipped pre-commercial quantities of CBD full spectrum oil containing THC, to support the development of a full spectrum product for the Brazilian market. TORONTO and RIONEGRO, Colombia, June 6, 2022 /CNW/ - PharmaCielo Ltd…
The Company expects Revenue to continue to grow – recently shipped 300 kg of CBD Full Spectrum Oil to a Spanish pharmaceutical company, announced entrance into Polish market, and shipments to Germany expected by late 2022. Steadily buildin…
The Company has shipped pharmaceutical grade CBD full spectrum oil containing THC to Extractions Solutions SL, to support pre-commercial development of a full spectrum product for the European market. TORONTO and RIONEGRO, COLOMBIA, May 24…
TORONTO and RIONEGRO, Colombia, May 11, 2022 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, Pha…
Poland is one of the largest cannabis markets in Europe by patient population, with more than 28,000 prescriptions issued to approximately 10,000 patients in the first nine months of 20211. The Company expects to begin shipping to Poland d…
Regulation to enable dried flower export and expand applications of CBD-based products passed by the Colombian Government on February 22, 2022 PharmaCielo's upstream and downstream scale and quality uniquely position the Company to be a do…
OMAHA, Neb., April 12, 2022--(BUSINESS WIRE)--Eckoh (AIM: ECK), the global provider of customer engagement security solutions, has expanded their cloud offering to include Microsoft Azure. A key part of Eckoh’s strategy is their commitment…
LONDON, April 12, 2022--(BUSINESS WIRE)--Eckoh (AIM: ECK), the global provider of customer engagement security solutions, has expanded their cloud offering to include Microsoft Azure. A key part of Eckoh’s strategy is its commitment to inv…
Builds on the passing of Regulation 227 in February, which implemented legal provisions to enable dried flower export and access to additional opportunities for CBD-based products. PharmaCielo expects to begin exporting dried flower in the…
TORONTO and RIONEGRO, Colombia, March 4, 2022 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, Ph…
PharmaCielo expects to begin exporting dried flower in the first half of 2022, with volumes growing through the remainder of the year. The Company's upstream and downstream scale and quality uniquely position it to be a formidable competit…
PharmaCielo expects to begin exporting dried flower in the first half of 2022, with volumes growing through the remainder of the year. The Company's upstream and downstream scale and quality uniquely position it to be a formidable competit…
The Company will start supplying the German market with three THC-dominant products, with commercial shipments expected to begin in late 2022. This is PharmaCielo's first sales agreement related to THC products. Represents a significant mi…
PharmaCielo is actively working with, and has recently shipped product to, established companies in Argentina, Brazil, Colombia and Paraguay. The Company's sales and technical teams are providing support to these customers as they conduct…